Embedded Files
Patents have been issued for the SubflowRx and its related components and the principals of the company continue to file new patent applications, trademarks, and copyrights to add to the value of our intellectual property (IP) portfolio. Active research and development by the principals in collaboration with other business entities is anticipated to greatly expand our current IP portfolio.
Patents have been issued for the SubflowRx and its related components and the principals of the company continue to file new patent applications, trademarks, and copyrights to add to the value of our intellectual property (IP) portfolio. Active research and development by the principals in collaboration with other business entities is anticipated to greatly expand our current IP portfolio.
Report abuse